Literature DB >> 30701620

Prescription opioid misuse and comorbid substance use: Past 30-day prevalence, correlates and co-occurring behavioral indicators in the 2016 National Survey on Drug Use and Health.

Timothy J Grigsby1, Jeffrey T Howard1.   

Abstract

BACKGROUND AND OBJECTIVES: Prescription opioid misuse has not been well examined in the context of comorbid substance use in representative samples of substance users. Past 30-day comorbid prescription opioid misuse and recreational substance use (eg, alcohol, marijuana, cocaine, etc.) was studied in a representative sample of substance users in the United States using the 2016 National Survey on Drug Use and Health (NSDUH).
METHODS: Prevalence of prescription opioid misuse with and without comorbid substance use was estimated with the 2016 NSDUH. Generalized linear modeling was used to describe demographic correlates of opioid and comorbid substance use and explore the relation of opioid and comorbid substance use with social and behavioral health indicators.
RESULTS: The majority of past month prescription opioid misusers reported use of other substances including cigarettes, alcohol, marijuana, or hard drugs (cocaine, methamphetamine, etc.). Males and younger respondents had a significantly higher risk of reporting past month prescription opioid misuse with illicit drug or polydrug use (p's < .01). Prescription opioid and polydrug users had the greatest odds of stealing property, selling drugs, having suicidal ideations, major depressive episode, and perceived treatment need in the past year compared to all other categories of prescription opioid misuse categories. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Prescription opioid misuse is likely a part of a larger set of psychological, behavioral, and mental health problems. More attention should be given to the profiles of recreational (non-medical) substance use involving prescription opioids to curtail the current opioid crisis and prevent other similar epidemics in the future. (Am J Addict 2019;XX:1-8).
© 2019 American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30701620     DOI: 10.1111/ajad.12866

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  14 in total

1.  Medical and Non-Medical Opioid Use at the Intersection of Gender and Sexual Identity: Associations with State Medical Cannabis Law Status in a U.S. National Sample of Adults.

Authors:  Pia M Mauro; Morgan M Philbin; Emily R Greene; Melanie S Askari; Silvia S Martins
Journal:  Arch Sex Behav       Date:  2021-11-09

2.  Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids.

Authors:  Jennifer L Brown; Gerald Cochran; M Aryana Bryan; Elizabeth Charron; T John Winhusen
Journal:  Subst Abus       Date:  2022       Impact factor: 3.984

3.  Co-ingestion of prescription drugs and alcohol in US adults aged 50 years or older.

Authors:  Ty S Schepis; Jason A Ford; Sean Esteban McCabe
Journal:  Hum Psychopharmacol       Date:  2021-07-08       Impact factor: 2.130

4.  Trends in Poly Drug Use-associated Deaths based on Confirmed Analytical Toxicology Results in Tehran, Iran, in 2011-2016.

Authors:  Maryam Akhgari; Fariba Sardari-Iravani; Masoud Ghadipasha
Journal:  Addict Health       Date:  2021-01

5.  Poly-prescription drug misuse across the life course: Prevalence and correlates across different adult age cohorts in the U.S.

Authors:  Jason A Ford; Ty S Schepis; Sean Esteban McCabe
Journal:  Int J Drug Policy       Date:  2020-11-20

6.  Nonmedical Prescription Opioid Use among a Sample of College Students: Prevalence and Predictors.

Authors:  Lisa L Weyandt; Bergljót Gyda Gudmundsdottir; Emily Shepard; Leslie Brick; Ashley Buchanan; Christine Clarkin; Alyssa Francis; Marisa Marraccini
Journal:  Pharmacy (Basel)       Date:  2021-05-28

7.  Publicly available machine learning models for identifying opioid misuse from the clinical notes of hospitalized patients.

Authors:  Brihat Sharma; Dmitriy Dligach; Kristin Swope; Elizabeth Salisbury-Afshar; Niranjan S Karnik; Cara Joyce; Majid Afshar
Journal:  BMC Med Inform Decis Mak       Date:  2020-04-29       Impact factor: 3.298

Review 8.  A systematic review of the effectiveness of employer-led interventions for drug misuse.

Authors:  Maxwell O Akanbi; Cassandra B Iroz; Linda C O'Dwyer; Adovich S Rivera; Megan Colleen McHugh
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

Review 9.  Prescription Drug Misuse: Taking a Lifespan Perspective.

Authors:  Ty S Schepis; Dalton L Klare; Jason A Ford; Sean Esteban McCabe
Journal:  Subst Abuse       Date:  2020-03-05

10.  A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.

Authors:  Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams
Journal:  BMC Public Health       Date:  2020-11-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.